HAO

The company operates through an integrated business model that combines product sales with health consultation services, leveraging digital platforms to reach customers across multiple provinces. Haoxi's distribution network includes partnerships with retail outlets, e-commerce platforms, and direct-to-consumer channels, enabling broad market penetration in tier-one through tier-three cities.

As a relatively small player in China's competitive health supplement industry, Haoxi faces significant competition from both domestic brands and international corporations with established market presence. The company has focused on expanding its product portfolio and enhancing its digital marketing capabilities to capture market share among younger, digitally-savvy consumers who increasingly prioritize health and wellness.

Haoxi Health Technology Limited trades on the NASDAQ stock exchange under the ticker symbol HAO, having completed its initial public offering to access U.S. capital markets. The company continues to navigate the evolving regulatory landscape governing health supplements in China while seeking to establish brand recognition in a fragmented marketplace.